Related Experiment Video
Updated: Jun 19, 2026

Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Natriuretic peptides and their evolving clinical applications
Markus Noveanu1, Mihael Potocki, Christian Mueller
1University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
Abstract:
Natriuretic peptides (NP) are quantitative plasma biomarkers of heart failure, which are widely used in clinical practice in many countries. NP levels are accurate in the diagnosis of heart failure in patients presenting with dyspnea. The use of NP improves patient management and reduces total treatment costs in patients with dyspnea. As NP levels quantify disease severity in patients with established heart failure, NP levels are powerful predictors of outcome in predicting death and rehospitalization. NP-guided therapy may improve morbidity in patients with chronic heart failure. Although NP levels also risk-stratify patients with many other conditions such as stable or unstable coronary artery disease, pulmonary embolism and community-acquired pneumonia, there is insufficient evidence on how patient outcome could be altered in patients identified as high risk.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Heart Failure Drugs: Diuretics
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

